Prescription drugs : companies typically charge more in the United States than in the United Kingdom : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives / United States General Accounting Office.
|Corporate Author:||United States.|
Washington, D.C. : The Office ; 1994]
> United States.
Prescription pricing > Great Britain.
Pharmaceutical industry > United States.
Pharmaceutical industry > Great Britain.
Drugs > Prices > United States.
Drugs > Prices > Great Britain.
Fees, Pharmaceutical > Great Britain.
Fees, Pharmaceutical > United States.
Costs and Cost Analysis > Great Britain.
Costs and Cost Analysis > United States.
Drug Industry > Great Britain.
Drug Industry > United States.
52 p. :
ill., charts ;
|Original Classification Number:||HD 9666.4 .U55 1994|
|Locate a Print Version:||
Find in a library
- Full view (original from University of Michigan)